đ¨ Abstract
ProQR Therapeutics reported a net loss of $10.6 million, or 11 cents per share, for the first quarter of 2025, missing Wall Street's projected loss of 9 cents per share. The Dutch biotech firm generated $4.8 million in revenue during the period.
Courtesy: wtop.com
Summarized by Einstein Beta đ¤
Suggested
Amber Heard reveals names of twin babies in Motherâs Day post -
A jazz club in Johannesburg plays its last songs and laments downtownâs decline -
How to view the full flower moon in the DC area -
Barcelona rallies to beat Real Madrid 4-3 despite MbappĂŠ hat trick to move closer to La Liga title -
A Republican push to sell public lands in the West is reigniting a political fight -
La tecnologĂa que definiĂł el internet moderno estĂĄ cambiando y Silicon Valley finalmente lo admite -
âThunderboltsâ and âSinnersâ top box office charts once more -
Nottingham Forest owner Marinakis appears to remonstrate with Espirito Santo after shock draw -
Pedersen makes it 2 wins out of 3 at Giro to take back pink jersey from Roglic -
Dortmund spoils Xabi Alonsoâs Leverkusen farewell and boosts its Champions League hopes -
Powered by MessengerX.io